Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies-Reference-Cited by-同舟云学术

Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies

Published:2018-07 Issue:7 Volume:18 Page:e183-e198
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Tiberi Simon,du Plessis Nelita,Walzl Gerhard,Vjecha Michael J,Rao Martin,Ntoumi Francine,Mfinanga Sayoki,Kapata Nathan,Mwaba Peter,McHugh Timothy D,Ippolito Giuseppe,Migliori Giovanni Battista,Maeurer Markus J,Zumla Alimuddin

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference140 articles.

1. Global tuberculosis report, 2017,2017

2. Effectiveness and safety of standardised shorter regimens for multidrug-resistant tuberculosis: individual patient data and aggregate data meta-analyses;Ahmad Khan;Eur Respir J,2017

3. Multidrug-resistant tuberculosis treatment failure detection depends on monitoring interval and microbiological method;Mitnick;Eur Respir J,2016

4. Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable tuberculosis: a prospective cohort study;Dheda;Lancet Respir Med,2017

5. Treatment outcomes in multidrug-resistant tuberculosis;Günther;N Engl J Med,2016

Cited by 283 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intensive reprocessing of reusable bronchoscopes can reduce the false positive rate of Xpert MTB/RIF caused by nucleic acid residue;Journal of Clinical Tuberculosis and Other Mycobacterial Diseases;2024-12

2. Innovative Strategies in Drug Repurposing to Tackle Intracellular Bacterial Pathogens;Antibiotics;2024-09-02

3. Cocrystal formulation design of 4-Aminosalicylic acid and isoniazid via spray-drying based on a ternary phase diagram toward simultaneous pulmonary delivery;Powder Technology;2024-09

4. Development of a luciferase-based Gram-positive bacterial reporter system for the characterization of antimicrobial agents;Applied and Environmental Microbiology;2024-08-21

5. Breaking the Cycle: Matrix Metalloproteinase Inhibitors as an Alternative Approach in Managing Tuberculosis Pathogenesis and Progression;ACS Infectious Diseases;2024-07-22